anti-P53-Regulated Apoptosis-Inducing Protein 1 (TP53AIP1) Antikörper

Human P53-Regulated Apoptosis-Inducing Protein 1 (TP53AIP1) Interaktionspartner

1. results show that constitutional truncating TP53AIP1 mutations predispose to CMM in the French population

2. Data indicate that p53-regulated apoptosis-inducing protein 1 (p53AIP1) inhibits the proliferation of PC-3M cells, arrests cell cycle at S/G2 (zeige STRN3 Antikörper)-M phase, decreases the abilities of invasion and migration and promotes cell apoptosis.

3. These studies indicate the critical role of p53AIP1 under DNA damaging stresses for cell fate determination in rheumatoid arthritis-fibroblast-like synovioctes containing the p53R248Q mutation.

4. Apak (zeige ZNF420 Antikörper) competes with p53 (zeige TP53 Antikörper) for binding to inhibit p53AIP1 expression.

5. large sample size of the combined cohort rejects a high-risk effect greater than 2.2 and indicates a limited role of TP53AIP1 in prostate cancer predisposition

6. p53AIP1 regulates the mitochondrial apoptotic pathway.

7. The expression of Ki67 (zeige MKI67 Antikörper) and p53 (zeige TP53 Antikörper) in various forms of leukoplakia point to the increasing instability of the genome in parallel with the severity of leukoplakia.

8. expression of the p53 (zeige TP53 Antikörper) mutant, R248Q, in liver cancer cells may enhance their drug resistance and upregulation of P-glycoprotein activity may contribute to this protective effect.

9. Roscovitine induced up-regulation of p53AIP1 protein and the depolarization of mitochondrial potential.

10. p53AIP1 gene is important for non-small cell lung cancer progression and may be a possible prognostic marker